Author:
Li Ling,Hu Man,Zhao Wei,Yue Jinbo,Yang Guoren,Zhao Shuqiang,Yu Jinming
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Koh WJ, Rasey JS, Evans ML, et al. Imaging of hypoxia in human tumors with 18F-fluoromisonidazole. Int J Radiat Oncol Biol Phys, 1992, 22: 199–212.
2. Yang DJ, Wallace S, Cherif A, et al. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. Radiology, 1995, 194: 795–800.
3. Chung JK, Chang YS, Lee YJ, et al. The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model. Ann Nucl Med, 1999, 13: 303–308.
4. Grönroos T, Eskola O, Lehtiö K, et al. Pharmacokinetics of 18F-FETNIM: a potential marker for PET. J Nucl Med, 2001, 42: 1397–1404.
5. Zhao W, Yang GR, Yu JM, et al. Hypoxic agent of 18F-fluoroerythronitroimidazole in human lung adenocarcinoma cell line. Chin J Nucl Med (Chinese), 2008, 28: 128–129.